On Jan. 10, the Centers for Medicare & Medicaid Services published proposed rules labeled as ‘‘policy and technical’’ changes to the Medicare Advantage (Part C) and Medicare Prescription Drug Benefit (Part D) Programs. Comments on the proposed rules are due March 7.
If adopted as drafted, these rules will not only impact how Medicare Advantage Organizations (MAO) and Part D Prescription Drug Plan (PDP) sponsors operate and interact with their contractors, beneficiaries, and the government, but will also impact the operations of all health care entities involved in providing drug products under Part C and Part D, including pharmacy benefit managers (PBMs), pharmacies, physicians, and pharmaceutical manufacturers.
Originally published in BNA’s Health Care Fraud Report on March 5, 2014.
Please see full alert below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.